AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05967117 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol (320mgI/mL) with 100kVp
Description: Patient undergoing CT scan with 100kVp protocol and using Iobrix inj. 320 (Taejoon pharm, Seoul, South Korea). CT images were obtained 55sec after Contrast media injection(100mL, 2mL/sec) with 20mL saline flushing.
Study NCT05967117 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol (270mgI/mL) with 100kVp
Description: Patient undergoing CT scan with 100kVp protocol and using Iobrix inj. 270 (Taejoon pharm, Seoul, South Korea). CT images were obtained 55sec after Contrast media injection(100mL, 2mL/sec) with 20mL saline flushing.
Study NCT05967117 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol (240mgI/mL) with 100kVp
Description: Patient undergoing CT scan with 100kVp protocol and using Iobrix inj. 240 (Taejoon pharm, Seoul, South Korea). CT images were obtained 55sec after Contrast media injection(100mL, 2mL/sec) with 20mL saline flushing.
Study NCT05716750 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Vitamin D
Description: 50,000 IU vit D treatment for 8 weeks
Study NCT04497259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical consultation
Description: Patients in the consultation arm will benefit from a classical face to face consultation at 6 and 9 months after surgery.
Study NCT06392295 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Para Aortic Radiation Therapy: Photon Therapy
Description: Participants will undergo five weeks of PA-RT daily, for up to 30 minutes per day for 25 days, Monday through Friday, consisting of a total dose of 50 grays (Gys) delivered in 25 fractions to the Clinical Tumor Volume (CTV).
Study NCT06392295 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Para Aortic Radiation Therapy: Proton Therapy
Description: Participants will undergo five weeks of PA-RT daily, for up to 30 minutes per day for 25 days, Monday through Friday, consisting of a total dose of 60 to 65 Gys delivered in 25 fractions to the Gross Tumor Volume (GTVn).
Study NCT06392295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy
Description: Androgen deprivation therapy will be administered as per standard of care.
Study NCT06392295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen Receptor Signaling Inhibitor
Description: Androgen receptor signaling inhibitor (ARSI) will be administered as per standard of care.
Study NCT05119881 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mirror therapy
Description: a mirror box will be placed in front of the participants with the mirror reflection side toward the non-paretic limb. The paretic arm will be placed behind the mirror, and the mirror box will block the vision of the paretic limb. Through this method, the patients can only view the movement of the non-paretic limb and its mirror reflection from the mirror. The participants will be instructed to move or perform functional tasks with their non-paretic limb and look at the mirror reflection of the non-paretic limb and mentally imagine that it is the paretic arm moving. At the same time, the participants will be encouraged to move the paretic arm along with the mirror reflection of the non-paretic arm. Activities practice during MT will include gross motor movements, fine motor movements, and functional tasks.
Study NCT05119881 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mirror therapy
Description: a mirror box will be placed in front of the participants with the mirror reflection side toward the non-paretic limb. The paretic arm will be placed behind the mirror, and the mirror box will block the vision of the paretic limb. Through this method, the patients can only view the movement of the non-paretic limb and its mirror reflection from the mirror. The participants will be instructed to move or perform functional tasks with their non-paretic limb and look at the mirror reflection of the non-paretic limb and mentally imagine that it is the paretic arm moving. At the same time, the participants will be encouraged to move the paretic arm along with the mirror reflection of the non-paretic arm. Activities practice during MT will include gross motor movements, fine motor movements, and functional tasks.
Study NCT05119881 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: The tDCS will be delivered by a DC-stimulator (Soterix Medical Inc, New York, USA) through 2 saline-soaked surface sponge electrodes (anodal electrode size: 25 cm2; cathode electrode size: 25 cm2). The anodal electrode will be placed over the ipsilesional M1 while the cathodal electrode will be placed over the contralesional M1. The stimulation intensity will be ramped up to 2mA in 15 seconds, and maintained at 2mA throughout the 20-minute stimulation for the MT+tDCS group.
Study NCT05119881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: The tDCS will be delivered by a DC-stimulator (Soterix Medical Inc, New York, USA) through 2 saline-soaked surface sponge electrodes (anodal electrode size: 25 cm2; cathode electrode size: 25 cm2). The anodal electrode will be placed over the ipsilesional M1 while the cathodal electrode will be placed over the contralesional M1. The stimulation intensity will be ramped up to 2mA in 15 seconds, and maintained at 2mA throughout the 20-minute stimulation for the MT+tDCS group.
Study NCT05119881 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: sham mirror therapy
Description: For the sham MT (s-MT) condition, the same mirror box will be used except that the mirror side will be made blurred to view; thus, the participants will not be able to view the mirror reflection of the paretic limb. The participants will perform the same activities as the real MT condition.
Study NCT05119881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham tDCS
Description: For the sham tDCS group, the electrodes will be placed on the brain regions as the real tDCS group. The intensity will first be ramped up to 2mA within 15 seconds and then the stimulator will be turned off gradually within the next 30 seconds.
Study NCT05494515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: the early swallowing rehabilitation program
Description: the early swallowing rehabilitation program based on the HRIM evaluation
Study NCT06428981 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: degenerative cervical diseases
Description: Including herniation of the intervertebral disc, ossification of the posterior longitudinal ligament, and spinal stenosis, resulting in cervical radiculopathy, or degenerative cervical myelopathy, and were scheduled to undergo anterior discectomy with fusion surgery.
Study NCT06191432 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Administration of Triticum Monococcum flour
Description: Patients will be administered a daily dose of 80g of flour of Triticum Monococcum (equivalent to 10g of gluten), which will be dissolved and cooked by the patients themselves. During the challenge, the severity of the symptoms will be recorded using a 10-points visual analog scale (VAS). The challenges will be stopped when clinical reactions will occur for at least 2 consecutive days (increase >3 in VAS) for either GI or extraintestinal symptoms.~Challenges will be considered positive if symptoms, which had been initially present, reappear after their disappearance on elimination diet, and if the GI and/or extraintestinal symptom's scores will be >30% compared to any eventual increase determined during the administration of the other wheat variety.
Study NCT06191432 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Administration of Triticum Aestivum flour
Description: Patients will be administered a daily dose of 80g of flour of Triticum Aestivum (equivalent to 10g of gluten), which will be dissolved and cooked by the patients themselves. During the challenge, the severity of the symptoms will be recorded using a 10-points visual analog scale (VAS). The challenges will be stopped when clinical reactions will occur for at least 2 consecutive days (increase >3 in VAS) for either GI or extraintestinal symptoms.~Challenges will be considered positive if symptoms, which had been initially present, reappear after their disappearance on elimination diet, and if the GI and/or extraintestinal symptom's scores will be >30% compared to any eventual increase determined during the administration of the other wheat variety.
Study NCT05261035 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stretching exercises
Description: For the stretching exercises group; the researchers explained to the women how to perform the stretching exercises through different visual materials like videos \& pictures, provided a demonstration of each step, and emphasized that they could perform this exercise at any comfortable position, standing, sitting, or dorsal.
Study NCT05261035 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: thermotherapy
Description: women were instructed to warm the water to 43-47 C° using a water thermometer or test it with the inner aspect of their wrists. They are also advised to avoid using too hot or too cold water. Then immerse their legs for 20 minutes in the warm water at a h
Study NCT05656625 — intervention group
Intervention type: OTHER
Intervention: descriptive
Description: The block performed (distal peripheral nerve block and/or brachial nerve block) and the volume applied, block performance time, first analgesia times, surgery times, surgery types, discharge times, presence of additional complaints will be recorded. The data obtained by grouping the patients according to the type of anesthesia applied (brachial plexus block and distal nerve blocks) will be subjected to statistical analysis.
Study NCT05458050 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PU sensor
Description: Device to assess microcirculation in sacrum area to find subjects at risk for pressure ulcer
Study NCT05563675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Long acting muscarinic antagonists (LAMAs) in the evening
Description: LAMAs administered at bedtime (8pm - 2am)
Study NCT05035576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OPN-019
Description: 400 mg OPN-019, 2 sprays per nostril (one dose)
Study NCT06461182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68-CXCR4
Description: Ga-68-CXCR4 for PET/CT procedure in Indolent B-cell Lymphoma
Study NCT06441045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Double Dose of Third-generation EGFR-TKI
Description: Double Dose of Third-generation EGFR-TKI
Study NCT06441045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Double Dose of Third-generation EGFR-TKI
Description: Double Dose of Third-generation EGFR-TKI
Study NCT06441045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intrathecal Pemetrexed
Description: Intrathecal Pemetrexed
Study NCT05467215 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pure oxygen (99%) from Praxair, Edmonton, DIN# 02014408
Description: Participants will receive oxygen (99%) or room air (placebo) delivered through a face mask at a flow rate of 10 litres/min for 2 minutes. The participants will be exposed twice to both conditions over 4 experiments at a minimum of 2 week intervals between each testing session.
Study NCT05467215 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pure oxygen (99%) from Praxair, Edmonton, DIN# 02014408
Description: Participants will receive oxygen (99%) or room air (placebo) delivered through a face mask at a flow rate of 10 litres/min for 2 minutes. The participants will be exposed twice to both conditions over 4 experiments at a minimum of 2 week intervals between each testing session.
Study NCT05148039 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietician advice
Description: Personalised dietetic advice
Study NCT05338346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATG-018
Description: Dose Escalation Phase:~For both dose escalation groups, subjects will receive a single dose of ATG-018 monotherapy on Cycle 1 Day 1 (C1D1) for single dose PK samples' collection. From the morning dose on Cycle 1 Day 2, twice daily dosing (except Dose Level 1: 5 mg QD) will be initiated. Subject(s) will receive intermittent dosing in a 3 days on/4 days off schedule in 21-day cycles until disease progression or unacceptable toxicity.~Dose Expansion Phase :~Dose Expansion Phase will begin at the defined MTD/RP2D for solid tumors and hematological malignancies groups, to further evaluate the safety, tolerability, and PDx profile of ATG-018. Subjects with solid tumors and hematological malignancies will be enrolled.
Study NCT05712057 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: high frequency rTMS over the right dlPFC
Study NCT05712057 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: high frequency rTMS over the right dlPFC
Study NCT05712057 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electrical scalp stimulation
Description: electrical scalp stimulation over the right dlPFC
Study NCT05712057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring
Description: Cognitive restructuring is a cognitive behavioral intervention through which participants learn how to think differently about stressful events in order to feel less emotional arousal.
Study NCT05712057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Restructuring
Description: Cognitive restructuring is a cognitive behavioral intervention through which participants learn how to think differently about stressful events in order to feel less emotional arousal.
Study NCT05712057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Awareness Training
Description: Emotional awareness training is a behavioral intervention through which participants learn how to identify and evaluate their emotions and the components that make up each emotion.
Study NCT00631501 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00631501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxycycline
Study NCT05429957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique
Description: Muscle energy technique (Post Isometric relaxation) three times per week for 8 weeks.~* MET of the Iliopsoas~* MET of Piriformis muscle~* MET of Quadratus Lumborum muscle~* MET of Erector Spinae muscle
Study NCT05429957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercises
Description: Aerobic exercise (treadmill walking) three times per week for 8 weeks~* Warm-up phase: in which each patient alternately steps their legs forward, backward, and sideways in each direction for 5 min~* Active phase: Treadmill speed was 3km/hour for 5 weeks and progress to 4km/hour after 5 weeks for 20 min.~* Cool down phase: During a cool down period take a deep breath with both arms overhead and exhale while bringing the arms down, shaking out the legs and arms for 5 min.
Study NCT05109676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: A questionnaire will be offered to patients and identify the schedules of administration of progesterone, the day and time of blood samples taken as part of the care, the potential adverse events associated with this administration.
Study NCT05355779 — intervention group
Intervention type: OTHER
Intervention: Not Application as this is a qualitative study
Description: Not Application as this is a qualitative study
Study NCT05482126 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Intraoperative Behavioral Testing
Description: During DBS surgery, tasks will be administered via a tablet PC or mounted monitor, and the subject may hold a response box, joystick, or dynamometer to record responses. During task periods, sensory stimuli will be delivered to the participant, who may be asked to perform a motor behavior in response. Stimuli will consist of audiovisual cues presented on a computer screen, vibration applied to specific parts of the body via a tactor, mild electrical pulses delivered through the skin of specific parts of the body via the attached EMG electrodes, and/or a movement of the arm or joint. Motor responses will consist of simple movements such as finger-tapping or hand-opening, or use of a joystick or dynamometer to move a computer cursor on the screen. Participants may be asked to respond only to a particular sensory stimulus and ignore others, in order to modulate the relevance of each stimulus to the task.
Study NCT05482126 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Behavioral Testing
Description: In the lab, tasks will be administered via a tablet PC or mounted monitor, and the subject may hold a response box, joystick, or dynamometer to record responses. During task periods, sensory stimuli will be delivered to the participant, who may be asked to perform a motor behavior in response. Stimuli will consist of audiovisual cues presented on a computer screen, vibration applied to specific parts of the body via a tactor, mild electrical pulses delivered through the skin of specific parts of the body via the attached EMG electrodes, and/or a movement of the arm or joint. Motor responses will consist of simple movements such as finger-tapping or hand-opening, or use of a joystick or dynamometer to move a computer cursor on the screen. Participants may be asked to respond only to a particular sensory stimulus and ignore others, in order to modulate the relevance of each stimulus to the task.
Study NCT06328998 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine rehabilitation treatment
Description: Routine rehabilitation treatment Includes oral rehabilitation, rehabilitation training for temporomandibular disorders, orthodontic treatment, and other physical therapy methods.which can alleviate symptoms by adjusting the bite, relaxing muscles, and increasing the range of motion of the temporomandibular joint.~Besides, it also Includes temporomandibular joint exercise training, relaxation training for facial muscles, and functional chewing training aimed at improving temporomandibular joint function and muscle balance.
Study NCT06328998 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine rehabilitation treatment
Description: Routine rehabilitation treatment Includes oral rehabilitation, rehabilitation training for temporomandibular disorders, orthodontic treatment, and other physical therapy methods.which can alleviate symptoms by adjusting the bite, relaxing muscles, and increasing the range of motion of the temporomandibular joint.~Besides, it also Includes temporomandibular joint exercise training, relaxation training for facial muscles, and functional chewing training aimed at improving temporomandibular joint function and muscle balance.
Study NCT06328998 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intra-articular Injection
Description: The patient is positioned to maximize mouth opening, and a needle is inserted approximately 10-12 mm in front of the tragus after touching the ankle prominence. An 8# injection needle is chosen and inserted upward and slightly forward into the joint cavity. A total of 2 mL of lidocaine hydrochloride injection solution is injected, repeated once every 5 days for a total of 15 days.
Study NCT06328998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: The patient is positioned to maximize mouth opening, and a needle is inserted approximately 10-12 mm in front of the tragus after touching the ankle prominence. An 8# injection needle is chosen and inserted upward and slightly forward into the joint cavity. A total of 2 mL of lidocaine hydrochloride injection solution is injected, repeated once every 5 days for a total of 15 days.
Study NCT05371652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant 75mg Orally Disintegrating Tablets (ODT)
Description: One rimegepant (BHV3000) 75mg orally disintegrating tablet (up to 1 tablet per day) at the time of their migraine attack
Study NCT04876755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBM-02
Description: MBM-02 is an HIF-1 and HIF-2 inhibitor.
Study NCT05643612 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Deep learning algorithm
Description: A sequential two-stage 3D spleen injury detection framework to identify splenic injury in the CT scans
Study NCT05218590 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Video rigid stylet
Description: Nasal intubation was performed using the video rigid stylet.
Study NCT05218590 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Video rigid stylet
Description: Nasal intubation was performed using the video rigid stylet.
Study NCT03617250 — intervention group
Intervention type: OTHER
Intervention: Disease Activity Score-28
Description: Assessment of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio and their association with Disease Activity Score-28
Study NCT05757336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
Description: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
Study NCT06272786 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy program.
Description: It will be applied to a rehabilitation program including joint range of motion exercises and physical therapy modalities by a physiotherapist at the Physical Therapy Hospital.
Study NCT06272786 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy program.
Description: It will be applied to a rehabilitation program including joint range of motion exercises and physical therapy modalities by a physiotherapist at the Physical Therapy Hospital.
Study NCT06272786 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block
Description: Bupivacaine hydrochloride will be used in this injection. 5 ml of bupivacaine hydrochloride 5% and 5 ml of saline will be drawn into a 10 ml syringe and ejection will be performed from the superior of the suprascapular noch under USG guidance.